Skip to main content

Announcing the release of the second version of the electronic reporting system for adverse drug reaction

Announcing the release of the second version of the electronic reporting system for adverse drug reaction
Publication Date
Applying Date
2013-12-09

The risk of rhabdomylosis/myopathy associated with the concomitant use of Simvastatin and Gemfibrozil

The risk of rhabdomylosis/myopathy associated with the concomitant use of Simvastatin and Gemfibrozil
Publication Date
Applying Date
2013-12-09

Diane-35 and risk of thromboembolism

Diane-35 and risk of thromboembolism
Publication Date
Applying Date
2013-12-09

Possibility of serious adverse events after intravenous administration of pethidine injection

Possibility of serious adverse events after intravenous administration of pethidine injection
Publication Date
Applying Date
2013-12-09

Possibility of serious adverse events after intravenous administration of pethidine injection

Possibility of serious adverse events after intravenous administration of pethidine injection
Publication Date
Applying Date
2013-12-09

Cefepime use and risk of nonconvulsive status epileptics in patients with kidney impairment

Cefepime use and risk of nonconvulsive status epileptics in patients with kidney impairment
Publication Date
Applying Date
2013-12-09

SFDA Statement About The Recent Updates Concerning Safe Use Of Azithromycin

SFDA Statement About The Recent Updates Concerning Safe Use Of Azithromycin
Publication Date
Applying Date
2013-12-09

Updates on Safety Information of Fentanyl Patches (Duragesic®)

Updates on Safety Information of Fentanyl Patches (Duragesic®)
Publication Date
Applying Date
2013-12-09

Saudi Food And Drug Authority Revokes Management of Preterm Labor Indication For Terbutaline

Saudi Food And Drug Authority Revokes Management of Preterm Labor Indication For Terbutaline
Publication Date
Applying Date
2013-12-09

Safety Warning : The Risk of death associated with intravenous administration of undiluted Ranitidine 50 mg/2ml

Safety Warning : The Risk of death associated with intravenous administration of undiluted Ranitidine 50 mg/2ml
Publication Date
Applying Date
2013-12-09
Subscribe to Drugs